About
Fermion develops, manufactures, and markets active pharmaceutical ingredients and offers contract development and manufacturing services for drug substances and drug products. It serves companies in the global generic market and companies focused on new chemical entities, with sites and R&D facilities in Finland.
Services
Generic API development, manufacturing and marketing
Develops, manufactures, and markets active pharmaceutical ingredients for the generic market and under exclusive contracts.
CDMO API development services
Supports drug development at all stages, including route selection, process optimization, scale-up, technology transfer, and regulatory support.
CDMO API commercial manufacturing
Provides commercial manufacturing of active pharmaceutical ingredients, including transfer of validated processes to Fermion sites.
Drug product contract manufacturing
Offers contract manufacturing services for drug products including semi-solids, liquids, oral solids, packaging, and technology transfer.
Technology transfer services
Supports transfer from another manufacturing site or transition from development to commercial manufacturing.
Regulatory support
Provides regulatory support for filings and market authorization preparation, including DMF-related support for CDMO customers.
Capabilities
- Assays and studies
- Analytical development
- QC testing
- Impurity profile analysis
- Process safety testing
- Reaction calorimetry
- DSC
- Method validation
- Process validation
- Scale and capacity
- Kilo scale unit in Espoo
- Pilot scale unit in Oulu
- Three manufacturing sites for drug products
- One packaging center for drug products
- Glass-lined reactors up to 6.3 m³
Instruments and platforms
- DSC
- Reaction calorimetry
Modalities and species
- Modalities
- Small molecule
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: sites in Finland
Details
- Type
- CRDMO
- Size
- 11-50 employees
- Based in
- Espoo, Finland
- Sites
- Hanko, Finland · Oulu, Finland · Turku, Finland · Salo, Finland
- Serves
- Global generic market, USA, China, Japan, Europe, Australia, Taiwan, Brazil, South-Korea, Mexico
Public records
- FDA drug establishment registration
- 3002807817 · ANALYSIS; API MANUFACTURE; LABEL source